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Both the Fujita-Ban and Hansch quantitative structure-activity relationship (QSAR) analyses,
attempted on the data set of 5,6-diarylspiro[2.4]hept-5-enes as the inhibitors of cyclooxygenase-2 (COX-2)
have helped to ascertain the role ofR- and X-substituents in explaining their observed biological inhibition
actions. From both approaches it is concluded that the substitution NH2 instead of Me at R is desirable. In
addition, the 3-F and/or 5-CI having smaller molar refraction values and the 4-CI and 4-CF3 possessing less
hydrophobic-cum-hydrogen acceptor property at X are the preferred substitutions of the aryl ring. For those
analogues whose COX-I inhibition data are available, the selectivity ratio, -logS [S = ICso(COX-
2)/lCso(COX-I)], is found to correlate with the electronic and hydrophobic-cum-hydrogen acceptor
parameters. From the derived significant correlation, it follows that the higher electron-withdrawing effect
produced by 3- and 4-X and the lower hydrophobic-cum-hydrogen accepting effect by 4-X in the aryl ring
are highly beneficial.
The chronic inflammatory conditions of arthritic
patients may be checked 1 by nonsteroidal
antiinflammatory drugs (NSAIDs) such as aspirin.
These drugs possess antiinflammatory, analgesic
and antipyretic activities but are not always
completely devoid of life-threatening side effects,
namely gastrointestinal haemorrhage, ulceration 1,2
and decreased renal function in some cases':", In
view of such problems, efforts are being made to
have new NSAIDs that possess antiinflammatory
activity without the toxic side effects.
Huang et al.5 have recently reported 5,6-
diarylspiro[2.4]hept-5-enes as orally active and
highly selective COX-2 inhibitors. These com-
pounds (Figure 1) have been shown to possess
promising pharmacological properties in adjuvant-
induced arthritis and edema analgesia models.
Fig. I-Structures of 5,6-diarylspiro[2,4]hept-5-enes
With a view to deriving quantitative structure-
activity relationships (QSARs), we report here the
Fujita-Ban analysis as well as the Hansch analysis
using the reported biological activities and
physicochemical parameters 6 of the substituents.
Methodology
First and foremost among the QSAR methods is
the model proposed by Hansch and co-workers6•11•
It was the seminal contribution of this group to
propose that the molar concentration (or dose) that
elicits a constant biological response of a drug
molecule is the linear function of its physico-
chemical parameters governing various types of
interactions. The lipophilicity, 1[, the electronic, c,
the Taft's steric, Es, the molar refraction, MR etc
are most common parameters of their formalism.
Multiple regression analysis'< " (MRA) is used to
derive the best QSARs. The resulting correlations
are assessed through a number of statistics
obtained in conjunction with such calculations.
The most important of these are the standard error
of the estimates, s, the correlation coefficient, r (or
the multiple correlation coefficient, R), the F-ratio,
a statistic for assessing the overall significance of
the derived equation and the confidence intervals
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(usually 95%) for the individual regression
coefficients in the equation.
The observation that in an analogue series the
substituents ought to contribute constant
increments or decrements to biological activity,
BA led Free and Wilson I 5 to develop an
extrathermodynamic QSAR approach, which is
based on an additivity principle as given by Eq. (1)
... (1)
Where X, is the jth substituent with a value of 1 if
present and 0 if not, aj is the contribution of the jth
substituent to BA, and Il is the overall average
activity. All activity contributions at each position
of substitution must sum to zero. The series of
linear equations so generated is solved by the
method of least squares for aj and Il. Fujita and
Banl6 later modified this method in which
symmetry equations are not required and Il was
interpreted as the theoretical biological activity
value of the unsubstituted reference compound of a
series. This definition then resembles more closely
to the Hammett's linear free energy relationship
(LFER), because the activity contributions aj now
refer to hydrogen in the same position of
substitution.
The compounds under study, their biological
effects alongwith various substitutional parameters
are listed in Table I. The activity data IC50
represents the concentration of a drug to
accomplish 50% inhibition of the human COX-2.
The same are expressed as -logIC5o on molar basis.
In addition, the COX-l activities are reported only
for a few compounds. For these analogues, the
selectivity ratio, S = IC5o(COX-2)/lC5o(COX-l),
computed as -logS are also included in Table I.
Results and Discussion
Table I shows that in the aryl ring at 4-position
the substituent X = F, CI, OMe etc are present in
all the compounds and none has X ~ H. Compound
Table I-QSAR parameters for 5,6-diarylspiro[2.4]hept-5-enes as highly selective cyclooxygenase inhibitors
(Figure I for structures)
-logICso(M)" -logSC
Compel! X R MR3.5 CJ3.4.5 7[4 HA4 14 IR Obsd Calc Calc Obsd Calc
Eq.4 F.B. Eq.7
1 4-F Me 0.206 0.06 0.14 0 I 0 8.\0 8.\0 8.29 2.83 2.71
2 4-F NH2 0.206 0.06 0.14 0 I I 8.52 .8.55 8.73 2.04 1.68
3 4-CI Me 0.206 0.23 0.71 0 0 0 9.00 8.75 8.74 3.49 3.42
4 4-CI NH2 0.206 0.23 0.71 0 0 I 9.00 9.20 9.18 2.15 2.40
5 4-0Me Me 0.206 -0.27 -0.02 I 0 0 8.30 8.34 8.27 2.06 2.37
6 4-0Me NH2 0.206 -0.27 -0.02 I 0 I 9.00 8.79 8.71 0.70 1.35
7 4-0CFJ Me 0.206 0.35 1.04 I 0 0 6.87 6.65 6.66 UA
8 4-0CF3 NH2 0.206 0.35 1.04 I 0 I 6.89 7.20 7.10 1.14 1.17
9 4-CF3 Me 0.206 0.54 0.88 0 0 0 8.70 8.49 8.63 UA
10 4-CF3 NH2 0.206 0.54 0.88 0 0 I 9.00 8.94 9.07 2.70 2.69
11 3-F,4-0Me Me 0.195 0.07 -0.02 I 0 0 8.00 8.35 8.20 UA
12 3-F,4-0Me NH2 0.195 0.07 -0.02 I 0 I 8.70 8.80 8.63 2.08 1.87
13 3-CI,4-0Me Me 0.706 0.\0 -0.02 I 0 0 7.77 8.20 8.11 UA
14 3-CI,4-0Me NH2 0.706 0.\0 -0.02 I 0 I 8.70 8.65 8.55 3.15 d
15 3-Br,4-0Me Me 0.991 0.12 -0.02 I 0 C 7.89 8.12 8.08 UA
16 3-Br,4-0Me NH2 0.991 0:12 -0.02 I 0 I 8.70 8.57 8.51 2.30 1.94
17 3,4-F2 Me 0.195 0.40 0.14 0 1 0 8.48 8.11 8.22 UA
18 3,4-F2 NH2 0.195 0.40 0.14 0 I I 8.52 8.56 8.65 2.49 2.20
19 3,4-CI2 Me 0.706 0.60 0.71 0 0 0 8.52 8.61 8.58 UA
20 3,4-CI2 NH2 0.706 0.60 0.71 0 0 I 9.00 9.06 9.02 2.58 2.96
21 3-CI,4-F Me 0.706 0.43 . 0.14 0 I 0 8.16 7.96 8.14 2.93 3.27
22 3-CI,4-F NH2 0.706 0.43 0.14 0 I I 8.82 8.4! 8.57 2.32 2.25
23' 3,5-CI2, 4-0Me Me 1.206 0.47 -0.02 I 0 0 8.22 8.06 8.09 UA
24 3,5-CI2,4-0Me NH2 1.206 0.47 -0.02 I 0 I 8.40 8.51 8.53 3.61
25 4-Me Me 0.206 -0.1'7 0.56 0 0 0 8.82 8.97
b 3.43 2.97
"The lC50 represents the concentration ofa compound for 50% inhibition of the enzyme COX-2; taken from ref. 5.
bOmitted compound in Fujita-Ban (F.B.) study.
"Selectivity ratio, S = lCso(COX-2)/ICso(COX-I) and UA is the reported uncertain activity value for the COX-I (ref. 5).
'The 'outlier' compounds in obtaining Eg. (7).
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1 with X = 4-F and R = Me has, therefore, retained
as the parent compound for calculating 1-1.
Compound 25 of this table is the lone compound
which has X = 4-Me. The same was ignored in
constructing the Fujita-Ban matrix, while COX-2
activities being as the dependent variable. The
matrix (omitted for the sake of brevity) has
resulted into 24 linear equations, each in 10
independent variables including parent con-
tribution 1-1. These were then solved by the method
of MRA and the results are given in Table II. The
derived statistical parameters, R, sand F are in
tune with high level of significance of these results
as the F-ratio is significant at 99% level
[FJQ,dO.01) = 4.10] and. R2-value accounts for
90% of the variance. From the calculated values of
substituents contributions (Table II), it follows that
the substitution NH2 instead of Me at R is
desirable as it has a positive contribution (= 0.437)
relative to Me. The sum of this contribution and
the contribution of parent compound (= 8.293)
leads to enhanced value of the -logICso (= 8.730).
In addition, the X-substitution in aryl ring such as
4-CI or 4-CF3' with their contribution of 0.448 and
0.339 respectively, further improves the inhibitory
activity of a compound, but none of the sub-
stituents seems to be appropriate for 3- and 5-
position of this aryl ring. For steric reasons, these
meta-positions better remain unsubstituted.
However, 3-F and/or 5-Cl, which are having least
negative contributions in aryl ring may be the
alternative selections in future synthetic efforts.
The calculated values of -logICso obtained by
adding the requisite substituents contribution to 1-1,
are in close agreement with the observed ones
(Table I). These findings are further corroborated
in the light of undermentioned Hansch type of
study.
Table 11-Fujita-Ban substituent contributions of 5,6-diaryl-
spiro[2.4] hept-S-enes to inhibition action against the enzyme
COX-2




4-X CI=0.448(±0.168), OMe~0.022(±0. 143),
OCF3~1.631(±0.221), CF3=0.339(±0.221)
S-X Cl~0.02\(±0.22\)
R NH2=0.437(±0.\ 0 \)
n=24, R=0.949, s=0.248, F(\0,\3)=\ \.690
Multiple regression analysis of the data for
above set of compounds (data points, n = 24),
yielded regression Eq. (2) for the COX-2 inhibition




-1.360(±0.166)I4 +0.43 7(±0.089)IR +9.858
n=24, R=0.945, s=0.219, F(5,18)=29.783 ... (2)
The ± data within parentheses are the 95%
confidence limits. The variable MR3,s represents
the sum of molar refractions of the meta-
substituents, X on the aryl moiety. The
hydrophobic contribution and hydrogen acceptor
property of para-substituents on this ring are
represented, respectively by 7t4 and HA4. Two
dummy variables, 1'4 and IR were chosen for the
subscripted positions so as to account for the
presence or absence of certain structural features
thereon. for example, an NH2 substitution at R is
indicated by 1, while a Me is assigned the value O.
Analogously, 14 is taken as 1 when X = 4-F and 0
otherwise. A large number of correlations in other
parameters such as electronic c, steric Es, Field F,
resonance R, van der Waals volume Vw etc were
attempted for X-substitution in various possible
combinations, but none of them could yield better
results than that of Eq. (2). The F-value of above
equation is significant at 99% level [F, 18(0.01)=
4.25] and R2 takes care of 89% of the variance in
the observed activity values. Though these
statistical parameters are hinting at the high level
of significance of Eq. (2) but the inter-correlation
matrix (not given here), obtained among
independent variables of this equation, has shown
that the orthogonality condition is not satis- fied
between HA4 and 14(r=0.58) variables. Also MR3,s
versus 7t4 and 7t4 versus HA4 correlations having
slightly higher R-values (= 0.38 in each) are not
truly independent. Eq. (2) as such may, therefore,
mislead the QSAR results. In order to improve its
significance further, the hydrophobic parameter 7t4,
the hydrogen acceptor paremeter HA4 and the
fluorine preferential parameter 14 were added
together and' their sum is denoted by a new
parameter, 134' The combination of these variables
is a result of the facts that the calculated regression
cofficients of these are all negative (Eq. 2), weigh
nearly equal in magnitude and have the
comparable ± confidence intervals. It is evident
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from Eq. (2) that the presence of either a highly
electronegative substituent, 4-F or a hydrogen-
acceptor substituent, 4-0Me in aryl ring reduces
the activity value (negative correlation coefficient
of 14 and HA4 respectively), while their low
hydrophobic character would increase it. These
two causes, therefore, operate in opposite
directions and the net gain in inhibiton action
would depend on the resultant value, expressed as
134' Generally, the increase in activity with the
decrease in hydrophobic property is an indicative
of some kind of polar interaction. However, the
attempted polar parameters such as the field, F or
resonance, R could not replace the 134parameter in
the follow-up correlation equations. Thus
employing the 134 along with MR3.5 and IR




n=24, R=0.930, s=0.233, F(3,20)=42.598 ... (3)
And consideration of all 25 data points (including




n=25, R=0.930, s=0.230, F(3,21)=44.514 ... (4)
Both these trivariant equations are highly sound
in statistical parlance and their results are superior
to that of a five variable Eq. (2). The F-value of
Eq. (3) and Eq. (4) are significant at 99% level
[F3,zo(0.01)= 4.94; F3,21(0.01)= 4.87] and their RZ_
values account for 84% of the variance. All the
variables of Eq. (4), which is derived from
complete data set, are mutually independent (r:
MR3,5 vs 134= 0.162; MR3,5 vs IR = 0.030 and 134vs
IR = 0.060). It also follows from Eq. (4) that NHz
instead of Me at R would lead to better inhibitors.
A large negative coefficient of 134, inter alia,
denotes that a less hydrophobic-cum-hydrogen
acceptor substitution on para-positIon in the
phenyl ring would be beneficial. To this effect, a
hydrogen acceptor substitution such as 4-S0zNH2
with a low 1t4 value (= -l.82) seems to be the most
appropriate. Thus a compound with X = 4-S02NH2
and R = NH2 is found to have the highest
theoretical activity value (-logICso = 1l.50, Eq. 4).
This compound is not described in the original
reference and should be synthesised and screened
for experimental activity value. In addition, the
meta-substituents in same phenyl ring having
smaller molar refraction value (a measure of steric
bulk) are desirable. In order to achieve this, both of
these positions better remain unsubstituted. The
smaller hydrogens at them may not sterically
hinder the orientation of a compound at the
receptor site during its action. Using Eq. (4), the
calculated values of -logIC5o, listed in Table I, are
highly in agreement with the observed ones.
For inhibition of the enzyme COX-I, only a few
compounds are reported active. Eight compounds
having uncertain activity (UA) values for this
enzyme are ignored in further study. The resulting
correlation between -logICso's of the COX-I and
the COX-2 is shown in Eq. (5)
-logICso(COX-l )=0.877 -logICso(COX-2)
n=17, r=0.394, s=0.768, F(I,15)=2.762 ... (5)
Obviously, it has emerged as a poor correlation,
which suggests that inhibition actions of the title
compounds are not the same at the COX -1 and the
COX-2. Alternatively, it may be stated that the two
enzymes function in different ways and the mode
of interaction of a compound at these enzymes will
also be different. In view of this fact, a large
number of physicochemical parameters were
correlated with selectivity ratio, -logS and one of




n=17, R=0.790, s=0.540, F(3,13)=6.746 ... (6)
Ignoring two compounds 14 and 24, which
followed off-the-trend behaviour, a regression Eq.




n=15, R=0.900, s=0.365, F(3,11)=15.659 ... (7)
In Eq. (6), the variable 0'3,4,5 represents the
summation of electronic parameters of various
substituents present at 3-, 4- and 5-positions in the
aryl ring. This variable is expressed as 0'3,4 (the
summed value of 3- and 4-substitutions) in Eq. (7)
as compound 24 being the only compound which
has a 5-CI substitution and was omitted in deriving
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this equation. The 'outlier' behaviour of this
compound may be attributed to its being loneliness
in the series. However, no immediate reason is
apparent for indifferent behaviour of compound
14. 'The F-value of Eq. (7) is significant at 99%. 2
level [F3,Il(O.Ol)=6.22] and R -value accounts for
81% of the variance. Further, this equation has
indicated that a Me- instead of NH2- substitution at
R leads to higher selectivity ratio. Likewise, in
second aryl ring the para-substitution having lower
hydrophobic- cum-hydrogen acceptor property and
meta- and para-substitutions. collectively pro-
ducing high electron-withdrawing effect are desir-
able. Using Eq. (7), the calculated -logS values
(Table I) closely resemble the observed ones and
all variables on the right hand side of this equation
are poorly inter-correlated (r: <J3,~ vs 134=0.17; <J3,4
vs IR=O.35 and 134vs IR=O.23).
In conclusion, it may be stated that the present
QSAR study provides a rationale for the design of
cyclooxygenase inhibitors, and a basis for
substituent-selection in drug-design strategy. It
also helps in deciphering the drug-receptor
interaction at the molecular level.
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